Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
glp 1 conference How Employers Can Control GLP-1 Costs Without Driving Employees to Quit GLP-1 Receptor Agonists in Flavor:Variety pack Targeted_Treatments
GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use | Current Obesity Reports | Springer Nature Link
F., Holst, J
Targeted_Treatments
Flavor:Variety pack
The SURPASS trial series spans five major trials with combined enrollment exceeding 10,000 participants, establishing the most comprehensive GLP-1 agonist evidence base in existence
US$ 21.43
US$ 28.68
US$ 22.72
US$ 23.66
US$ 29.16
